Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Bensimon

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 25, 2002
Survival endpoint: proGilbert Bensimon
Expert Opinion on Drug Safety|October 27, 2004
The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosisGilbert Bensimon, Adam Doble
Lancet (London, England)|November 1, 2025
Stratifying IL-2 therapy in ALS: integrating biomarkers - Authors' replyGilbert Bensimon, P Nigel Leigh, Timothy Tree
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 8, 2009
Brain and plasma riluzole pharmacokinetics: effect of minocycline combinationAline Milane, Lionel Tortolano, Christine Fernandez, et al.
Journal of Neurochemistry|July 20, 2007
Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrierAline Milane, Christine Fernandez, Sarah Vautier, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Xaliproden in amyotrophic lateral sclerosis: early clinical trialsLucette Lacomblez, Gilbert Bensimon, Patrice Douillet, et al.
Brain : a Journal of Neurology|November 26, 2008
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyGilbert Bensimon, Albert Ludolph, Yves Agid, et al.
Plos One|October 2, 2012
Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosisYann Nadjar, Paul Gordon, Philippe Corcia, et al.
Neuroscience Letters|January 17, 2009
Interactions between riluzole and ABCG2/BCRP transporterAline Milane, Sarah Vautier, Hélène Chacun, et al.
Neuroscience Letters|February 9, 2010
P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosisAline Milane, Christine Fernandez, Luc Dupuis, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 25, 2002
Survival endpoint: proGilbert Bensimon
Expert Opinion on Drug Safety|October 27, 2004
The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosisGilbert Bensimon, Adam Doble
Lancet (London, England)|November 1, 2025
Stratifying IL-2 therapy in ALS: integrating biomarkers - Authors' replyGilbert Bensimon, P Nigel Leigh, Timothy Tree
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 8, 2009
Brain and plasma riluzole pharmacokinetics: effect of minocycline combinationAline Milane, Lionel Tortolano, Christine Fernandez, et al.
Journal of Neurochemistry|July 20, 2007
Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrierAline Milane, Christine Fernandez, Sarah Vautier, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Xaliproden in amyotrophic lateral sclerosis: early clinical trialsLucette Lacomblez, Gilbert Bensimon, Patrice Douillet, et al.
Brain : a Journal of Neurology|November 26, 2008
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyGilbert Bensimon, Albert Ludolph, Yves Agid, et al.
Plos One|October 2, 2012
Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosisYann Nadjar, Paul Gordon, Philippe Corcia, et al.
Neuroscience Letters|January 17, 2009
Interactions between riluzole and ABCG2/BCRP transporterAline Milane, Sarah Vautier, Hélène Chacun, et al.
Neuroscience Letters|February 9, 2010
P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosisAline Milane, Christine Fernandez, Luc Dupuis, et al.
Pageof 4